Compare NUVB & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | ARCO |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | Uruguay |
| Employees | 291 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | N/A | 2011 |
| Metric | NUVB | ARCO |
|---|---|---|
| Price | $4.52 | $8.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $11.38 | $8.60 |
| AVG Volume (30 Days) | ★ 3.2M | 858.9K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 3.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $205.55 | $11.88 |
| Revenue Next Year | $58.57 | $4.26 |
| P/E Ratio | ★ N/A | $7.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $6.51 |
| 52 Week High | $9.75 | $8.98 |
| Indicator | NUVB | ARCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 59.14 |
| Support Level | $4.06 | $7.04 |
| Resistance Level | $5.55 | $8.98 |
| Average True Range (ATR) | 0.24 | 0.25 |
| MACD | 0.08 | 0.06 |
| Stochastic Oscillator | 59.35 | 87.50 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.